# US 2025/0082655 A1 · Use of heterocyclic compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082655 A1
- Document ID: US20250082655A1
- Status: Published application
- Kind: A1
- Application number: 18/728,611
- Filed: 2023-01-18
- Published: 2025-03-13
- Earliest claimed: 2022-01-27
- Assignees: Wuhan Createrna Science and Technology Co., Ltd.
- Applicants: Wuhan Createrna Science and Technology Co., Ltd.
- Inventors: Yongkai CHEN; Xiaodan GUO; Jun LOU; Chaodong WANG
- Web page: https://patentgrep.com/patent/US20250082655A1

## CPC

- A61K 31/675: having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A61P 11/00: Drugs for disorders of the respiratory system
- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61K 31/501: not condensed and containing further heterocyclic rings
- A61K 31/5025: ortho- or peri-condensed with heterocyclic ring systems
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 11/14: Antitussive agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed is a use of a heterocyclic compound. Specifically disclosed is a use of a heterocyclic compound in the preparation of a drug for treating and/or preventing respiratory diseases; the heterocyclic compound is a substance X, a tautomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of the pharmaceutically acceptable salt thereof; the substance X is a compound as shown in formula I or a compound as shown in formula II; the heterocyclic compound of the present invention has a good cough relieving effect.

## Claims

### Claim 1

A method for treating respiratory diseases; comprising administering to a subject in need thereof a therapeutically effective amount of a heterocyclic compound, the heterocyclic compound is a substance X, a tautomer thereof, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of the pharmaceutically acceptable salt thereof; the substance X is a compound of formula I:
wherein ring A is a 9- to 10-membered heteroaromatic ring containing 3 nitrogen atoms;
Y is —O— or —C(═O)—;
R1 is H or
R1-1 and R1-2 are independently H or C1-C6 alkyl;
R is independently H, F, —Cl, —Br, —CN, —ORa, —NRbRc, C1-C3 alkyl, C3-4 cycloalkyl, C1-C3 alkyl substituted by 1, 2, 3, or 4 R2-1, or C3-4 cycloalkyl substituted by 1, 2, 3, or 4 R2-2;
Ra is independently H or C1-C3 alkyl;
Rb and Rc are independently H or C1-C3 alkyl;
R2-1 and R2-2 are independently F, —Cl, —Br, or —OH;
p is 0, 1, 2, 3, 4, or 5.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the compound of formula I has a structure as shown in formula I-A or I-B:
R1 is H or
R1-1 and R1-2 are independently H or C1-C6 alkyl;
R2, R3, R4, R5, and R6 are independently H, F, —Cl, —Br, —CN, —ORa, —NRbRc, C1-C3 alkyl, C3-4 cycloalkyl, C1-C3 alkyl substituted by 1, 2, 3, or 4 R2-1, or C3-4 cycloalkyl substituted by 1, 2, 3, or 4 R2-2.

### Claim 3 (depends on 2)

The method according to claim 2, wherein one or more of the following conditions is satisfied:
(1) R2, R3, R4, R5, and R6 are independently H, F, —Cl, —Br, —CN, —ORa, —NRbRc, C1-C3 alkyl, C3-4 cycloalkyl, or C1-C3 alkyl substituted by 1, 2, 3, or 4 R2-1;
(2) Rb and Rc are independently C1-C3 alkyl;
(3) R2-1 and R2-2 are F.

### Claim 4 (depends on 1)

The method according to claim 1, wherein one or more of the following conditions is satisfied:
(1) in R1-1 and R1-2, the C1-C6 alkyl is independently methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl;
(2) in R2, R3, and R4, the C1-C3 alkyl is independently methyl, ethyl, n-propyl, or isopropyl;
(3) in R2, R3, and R4, the C1-C3 alkyl substituted by 1, 2, 3, or 4 R2-1 is independently —CH2F, —CHF2, —CF3, —CH2CH2F, —CH2CHF2, or —CH2CF3;
(4) in R2, R3, and R4, the C3-4 cycloalkyl is independently cyclopropyl or cyclobutyl;
(5) in Ra, the C1-C3 alkyl is independently methyl, ethyl, n-propyl, or isopropyl;
(6) in Rb and Rc, the C1-C3 alkyl is independently methyl, ethyl, n-propyl, or isopropyl.

### Claim 5 (depends on 4)

The method according to claim 4, wherein one or more of the following conditions is satisfied:
(1) in R1-1 and R1-2, the C1-C6 alkyl is tert-butyl;
(2) in R2, R3, and R4, the C1-C3 alkyl is methyl;
(3) in R2, R3, and R4, the C1-C3 alkyl substituted by 1, 2, 3, or 4 R2-1 is independently —CHF2 or —CF3;
(4) in R2, R3, and R4, the C3-4 cycloalkyl is cyclopropyl;
(5) in Ra, the C1-C3 alkyl is methyl;
(6) in Rb and Rc, the C1-C3 alkyl is methyl.

### Claim 6 (depends on 1)

The method according to claim 1, wherein one or more of the following conditions is satisfied:
(1) R1-1 and R1-2 are independently H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, or tert-butyl;
(2) Ra is independently H, —CH3, or —CH2CH3;
(3) Rb and Rc are independently H, —CH3, or —CH2CH3;
(4) p is 1, 2, or 3.

### Claim 7 (depends on 6)

The method according to claim 6, wherein one or more of the following conditions is satisfied:
(1) R1-1 and R1-2 are independently H or tert-butyl;
(2) Ra is independently H or —CH3;
(3) Rb and Rc are —CH3.

### Claim 8 (depends on 2)

The method according to claim 2, wherein R2, R3, and R4 are independently H, F, —Cl, —Br, —CN, —OH, —OCH3, —NH2, —N(CH3)2, —CH3, cyclopropyl, —CH2F, —CHF2, or —CF3.

### Claim 9 (depends on 2)

The method according to claim 2, wherein one or more of the following conditions is satisfied:
(1) R1 is H,
(2) R2 is H, F, —Cl, —CH3, —CH2F, —CHF2, or —CF3;
(3) R3 is H, F, —Cl, —CN, —OH, —OCH3, —N(CH3)2, —CH3, or cyclopropyl;
(4) R4 is H, F, or —CF3;
(5) R5 is F, —Cl, —CH3, —CHF2, or —CF3;
(6) R6 is H, F, or —Cl.

### Claim 10 (depends on 2)

The method according to claim 2,

### Claim 11 (depends on 1)

The method according to claim 1, wherein the compound of formula I is any one of the following compounds:

### Claim 12 (depends on 1)

The method according to claim 1, wherein the respiratory disease is a cough.

### Claim 13 (depends on 8)

The method according to claim 8, wherein R2, R3, and R4 are independently H, F, —Cl, —CN, —OH, —OCH3, —N(CH3)2, —CH3, cyclopropyl, —CHF2, or —CF3.

### Claim 14 (depends on 9)

The method according to claim 9, wherein one or more of the following conditions is satisfied:
(1) R2 is F, —CHF2, or —CF3;
(2) R5 is —CF3;
(3) R6 is F.

### Claim 15 (depends on 12)

The method according to claim 12, wherein the cough is an acute cough, a chronic cough, a refractory chronic cough, or an idiopathic chronic cough.
